AstraZeneca’s Imfinzi approved in US as first and only perioperative immunotherapy for patients with early gastric and GEJ cancers: Cambridge, UK Thursday, November 27, 2025, 09 ...
Y our local news team has some news of its own to report. Changes are coming to our team.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback